Escala de Depressão Pós-natal de Edimburgo para triagem no sistema público de saúde

Figueira, Patrícia; Corrêa, Humberto; Malloy-Diniz, Leandro Fernandes; Romano-Silva, Marco Aurélio

doi:10.1590/s0034-89102009000800012

Cited by 38 publications

(18 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Em outros trabalhos, a prevalência variou de 7,2% a 39,4% 7,18,19,20,21 . A divergência entre as prevalências encontradas pode ser explicada pela diferença no momento da aferição, no ponto de corte utilizado na EPDS, no instrumento usado para identificar a depressão, além dos fatores culturais e socioeconômicos da região em que a pesquisa foi realizada.…”

Section: Discussionunclassified

Depressão entre puérperas: prevalência e fatores associados

2017

View full text Add to dashboard Cite

show abstract

Section: Discussionunclassified

Depressão entre puérperas: prevalência e fatores associados

2017

View full text Add to dashboard Cite

show abstract

“…The original sample size calculation was based on a prevalence of postpartum depression ranging from 26.9 to 39.9% according the previous studies conducted in similar population [17, 46]. We designed this study to detect a 5% reduction in the prevalence of EPDS ≥11 from baseline of 27% to 22% after the study intervention, compared with controls.…”

Section: Methodsmentioning

confidence: 99%

Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial

Vaz

Farias²,

Adegboye

et al. 2017

BMC Pregnancy Childbirth

View full text Add to dashboard Cite

BackgroundLow n-3 polyunsaturated fatty acids (PUFAs) has been linked to depression, but the preventive effect of n-3PUFAs supplementation on maternal depression needs further investigation. We aimed to evaluate the efficacy of a daily dose of n-3 PUFAs supplementation (fish oil) on the prevention of postpartum depression (PPD).MethodsA randomized, placebo-controlled, double blind trial was designed and nested into a cohort study conducted in Rio de Janeiro, Brazil. Sixty pregnant women identified as being at risk for PPD were invited and randomly assigned to receive fish oil capsules [1.8 g (1.08 g of Eicosapentaenoic (EPA) and 0.72 g of Docosapentaenoic (DHA) acids)] or placebo (control). The Edinburgh Postnatal Depression Scale (EPDS) was scored at 5–13 (T0, baseline), 22–24 (T1), 30–32 weeks of gestation (T2) and 4–6 weeks’ postpartum (T3). Supplementation started at week 22–24 of gestation (T1) and lasted for 16 weeks. Serum fatty acids were assayed to evaluate compliance. Prevalence of EPDS ≥11 was the primary outcome, and mean and changes in EPDS score, length of gestation, and birth weight the secondary outcomes. Linear mixed-effect (LME) and random-intercept logistic regression models were performed to test the effect of fish oil supplementation on prevalence of EPDS ≥11 and EPDS scores variation.ResultsIn intention-to-treat (ITT) analysis, at 30–32 weeks’ gestation women in the fish oil presented higher serum concentration of EPA, DHA and lower n-6/n-3 ratio comparing to the control group. There were no differences between intervention and control groups in the prevalence of EPDS ≥11, EPDS scores over time, or in changes in EPDS scores from pregnancy to postpartum in either the ITT or per-protocol analyses. Women in the fish oil group with previous history of depression presented a higher reduction on the EPDS score from the second to the third trimester in the fish oil comparing to the control group in the ITT analyses [−1.0 (−3.0–0.0) vs. -0.0 (−1.0–3.0), P = 0.038). These results were confirmed on the LME model (β = −3.441; 95%CI: -6.532– -0.350, P = 0.029).ConclusionDaily supplementation of 1.8 g of n-3 PUFAs during 16 weeks did not prevent maternal depressive symptoms in a sample of Brazilian women.Trial registrationClinicalTrials.gov Identifier: NCT01660165. Retrospectively registered on 24 May 2012.

show abstract

“…As for other psychiatric disorders during the postpartum, maternal depression is also associated with increased risk of manifestation of aggressive behavior, including suicide attempts and infanticide. It is noteworthy that the change in the baby's development is directly linked to the type of depression that the mother is suffering [7][8][9] . Depression can be transient and/or prolonged, and the transient depression can be of no significant influence on child development.…”

Section: Introductionmentioning

confidence: 99%

Validation of the Scale of Perceived Self-Efficacy of Maternal Parenting in Brazilian Sample

Tristão¹,

Neiva

Barnes

et al. 2015

J. Hum. Growth Dev.

View full text Add to dashboard Cite

Introduction: self-efficacy matches the belief that a person has that she is able to produce the results she wants to achieve. The beliefs of self-efficacy that parents have about the baby emerge as a powerful predictor of positive parenting. Objective: this study aimed to evaluate the maternal self-efficacy behavior in hospitalized mothers and validate an instrument for measuring this concept developed and validated in England by Barnes and Adamson-Macedo, in 2007. Method: this crosssectional exploratory study convenience cohort comprised 87 mothers of newborn babies, 26 premature and 61 full-term infants. The scale Perceived Maternal Parenting Self-Efficacy (PMP S-E), which consists of 20 items that represent four subscales was tested for reliability and validity. Results: the internal consistency of the scale PAEPM reached a value of .86, the internal consistency and reliability estimates for each of the subscales also reached acceptable values. Exploratory Factor Analysis (EFA) confirmed the validity of the construct and the scores of self-efficacy were normally distributed for both subgroups and total sample. Conclusions: PMP S-E scale proved to be an easy application tool and psychometrically robust, reliable and valid for use with mothers of hospitalized new-borns both premature as the term clinically stable. It is a reliable method of identifying mothers of babies who need more support from the hospital staff.

show abstract

Escala de Depressão Pós-natal de Edimburgo para triagem no sistema público de saúde

Cited by 38 publications

References 19 publications

Depressão entre puérperas: prevalência e fatores associados

Depressão entre puérperas: prevalência e fatores associados

Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial

Validation of the Scale of Perceived Self-Efficacy of Maternal Parenting in Brazilian Sample

Contact Info

Product

Resources

About